US Patent 11345751 FcRn antibodies and methods of use thereof
Patent 11345751 was granted and assigned to Momenta Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11345751 FcRn antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
